EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Protein Identification for Stroke Progression via Mendelian Randomization in Million Veteran Program and UK Biobank

Andrew R Elmore, Nimish Adhikari, April E Hartley, Hugo Javier Aparicio, Daniel C Posner, Gibran Hemani, Kate Tilling, Tom R Gaunt, Peter W F Wilson, Juan P Casas, John Michael Gaziano, George Davey Smith und 3 weitere

Stroke · 2024

DOI: 10.1161/strokeaha.124.047103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stroke, 2024. Verfasst von Andrew R Elmore und 14 weiteren Autor:innen. Beteiligte Einrichtung: NIHR Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and University of Bristol, United Kingdom (A.R.…. Hauptthemen laut MEDLINE: Mendelian Randomization Analysis, Biological Specimen Banks, Genome-Wide Association Study, Stroke. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CSRD VA, NINDS NIH HHS, BLRD VA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Individuals who have experienced a stroke, or transient ischemic attack, face a heightened risk of future cardiovascular events. Identification of genetic and molecular risk factors for subsequent cardiovascular outcomes may identify effective therapeutic targets to improve prognosis after an incident stroke. METHODS: We performed genome-wide association studies for subsequent major adverse cardiovascular events (MACE; n cases =51 929; n controls =39 980) and subsequent arterial ischemic stroke (AIS; n cases =45 120; n controls =46 789) after the first incident stroke within the Million Veteran Program and UK Biobank. We then used genetic variants associated with proteins (protein quantitative trait loci) to determine the effect of 1463 plasma protein abundances on subsequent MACE using Mendelian randomization. RESULTS: Two variants were significantly associated with subsequent cardiovascular events: rs76472767 near gene RNF220 (odds ratio, 0.75 [95% CI, 0.64–0.85]; P =3.69×10 −8 ) with subsequent AIS and rs13294166 near gene LINC01492 (odds ratio, 1.52 [95% CI, 1.37–1.67]; P =3.77×10 −8 ) with subsequent MACE. Using Mendelian randomization, we identified 2 proteins with an effect on subsequent MACE after a stroke: CCL27 ([C-C motif chemokine 27], effect odds ratio, 0.77 [95% CI, 0.66–0.88]; adjusted P =0.05) and TNFRSF14 ([tumor necrosis factor receptor superfamily member 14], effect odds ratio, 1.42 [95% CI, 1.24–1.60]; adjusted P =0.006). These proteins are not associated with incident AIS and are implicated to have a role in inflammation. CONCLUSIONS: We found evidence that 2 proteins with little effect on incident stroke appear to influence subsequent MACE after incident AIS. These associations suggest that inflammation is a contributing factor to subsequent MACE outcomes after incident AIS and highlights potential novel targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mendelian Randomization AnalysisBiological Specimen BanksGenome-Wide Association StudyStrokeVeteransHumansMaleFemaleUnited KingdomMiddle AgedAgedDisease ProgressionPolymorphism, Single NucleotideIschemic StrokeRisk FactorsQuantitative Trait LociUK Biobank

Stichwörter der Autor:innen

blood proteinsgenome-wide association studyinflammationprognosisstroke

Autor:innen und Institutionen

  • NIHR Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and University of Bristol, United Kingdom (A.R.E., A.E.H., G.H., K.T., T.R.G., G.D.S., L.P.).
  • MRC Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, United Kingdom (A.R.E., A.E.H., G.H., K.T., T.R.G., G.D.S., L.P.).
  • Veteran's Affairs Healthcare System, Boston, MA (N.A., D.C.P., J.P.C., J.M.G., K.C., G.M.P.).
  • Department of Biostatistics, Boston University School of Public Health, MA (N.A., G.M.P.).
  • Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, MA (H.J.A.).
  • Boston Medical Center, MA (H.J.A.).

Förderung

  • CSRD VA
  • NINDS NIH HHS
  • BLRD VA
  • NHLBI NIH HHS
  • Medical Research Council

Zitieren

APA

Elmore, A. R., Adhikari, N., Hartley, A. E., Aparicio, H. J., Posner, D. C., Hemani, G., Tilling, K., Gaunt, T. R., Wilson, P. W. F., Casas, J. P., Gaziano, J. M., Davey Smith, G., Paternoster, L., Cho, K., & Peloso, G. M. (2024). Protein Identification for Stroke Progression via Mendelian Randomization in Million Veteran Program and UK Biobank. Stroke. https://doi.org/10.1161/strokeaha.124.047103

Vancouver

Elmore AR, Adhikari N, Hartley AE, Aparicio HJ, Posner DC, Hemani G, et al. Protein Identification for Stroke Progression via Mendelian Randomization in Million Veteran Program and UK Biobank. Stroke. 2024. doi:10.1161/strokeaha.124.047103

BibTeX
@article{Elmore2024,
  author = {Elmore, Andrew R and Adhikari, Nimish and Hartley, April E and Aparicio, Hugo Javier and Posner, Daniel C and Hemani, Gibran and Tilling, Kate and Gaunt, Tom R and Wilson, Peter W F and Casas, Juan P and Gaziano, John Michael and Davey Smith, George and Paternoster, Lavinia and Cho, Kelly and Peloso, Gina M},
  title = {Protein Identification for Stroke Progression via Mendelian Randomization in Million Veteran Program and UK Biobank},
  journal = {Stroke},
  year = {2024},
  doi = {10.1161/strokeaha.124.047103}
}
Kostenlos starten →